Ocuphire Pharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ocuphire Pharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Ocuphire Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 26M shares, a 23.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 26M +4.99M +23.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 25.1M +4.14M +19.8% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 24M +3.12M +14.9% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 22.6M +1.81M +8.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 21M +886K +4.41% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 20.9M +1.73M +9.03% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 20.9M +2.02M +10.7% Dec 31, 2022 10-K 2024-03-08
Q3 2022 20.8M +3.51M +20.3% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 20.1M +3.21M +19% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 19.2M +8.28M +75.8% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 18.8M +7.96M +73.2% Dec 31, 2021 10-K 2023-03-30
Q3 2021 17.3M +12.8M +286% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 16.9M +12.9M +320% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 10.9M +6.91M +172% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 10.9M +8.03M +282% Dec 31, 2020 10-K 2022-03-24
Q3 2020 4.48M +464K +11.5% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 4.02M 0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 4.02M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 2.85M -270K -8.66% Dec 31, 2019 10-K 2021-03-11
Q3 2019 4.02M -27.7M -87.3% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 4.02M -27.7M -87.3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 4.02M -27.7M -87.3% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 3.12M -28.6M -90.2% Dec 31, 2018 10-K 2020-02-21
Q3 2018 31.8M +3.29M +11.6% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 31.7M +3.29M +11.6% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 31.7M -213M -87% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 31.7M +7.99M +33.7% Dec 31, 2017 10-K 2019-03-07
Q3 2017 28.5M -209M -88% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 28.5M -185M -86.7% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 245M +31.8M +14.9% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 23.7M -174M -88% Dec 31, 2016 10-K 2018-03-09
Q3 2016 237M +56.6M +31.3% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 213M +32.6M +18.1% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 213M +34M +19% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 197M +19.2M +10.7% Dec 31, 2015 10-K 2017-02-24
Q3 2015 181M +2.49M +1.4% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 181M +2.47M +1.39% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 179M +2.57M +1.45% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 178M +31.5M +21.5% Dec 31, 2014 10-K 2016-03-14
Q3 2014 178M +43.8M +32.6% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 178M +58.3M +48.7% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 177M +57.2M +47.9% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 147M +27.3M +22.8% Dec 31, 2013 10-K 2015-03-16
Q3 2013 134M +39.1M +41% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 120M +24.5M +25.7% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 119M +24.1M +25.3% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 119M +24.1M +25.3% Dec 31, 2012 10-K 2014-03-21
Q3 2012 95.3M +80K +0.08% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 95.3M +108K +0.11% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 95.3M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 95.3M +11.2M +13.3% Dec 31, 2011 10-K 2013-03-22
Q3 2011 95.3M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 95.2M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 84.2M Dec 31, 2010 10-K 2012-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.